Items stated in the management plan
FormulatedEach line is the climb from the baseline the document states to the target it sets. The slope is scaled against the largest climb in this document. The increase shown by the dotted line is calculated from the two reported figures because the company did not provide the amount of growth.
| Item | Details |
|---|---|
| Plan name | Medium-Term Management Plan 2029 |
| Plan period | 2027/09–2029/09 (three-year financial plan) |
| Progress against the plan | Formulated |
| Sales Target | 2026/09 actual: ¥5.80 billion → 2029/09 plan: ¥8.11 billion(CAGR +11.7%) |
| Operating profit target | 2026/09 actual: ¥190 million → 2029/09 plan: ¥530 million(Approximately 2.7 times FY26) |
| Payout ratio / DOE policy | As cash inflows will be allocated to growth investments, the company generally expects to pay no dividends. The applicable period is Not disclosed. |
| Total investment plan | Growth investment: ¥800 million–¥1.2 billion (growth investment section for the plan period) |
| Investment amount by sector | Field Capital investment for opening test centers / Amount Not disclosed, Field System development costs for the contract and licensing businesses / Amount Not disclosed |
| Segment target | Segment Test Center Business / Net Sales ¥4.70 billion / Segment profit ¥520 million / Timing 2029/09, Segment Contract Manufacturing Business / Net Sales ¥2.13 billion / Segment profit ¥310 million / Timing 2029/09, Segment Licensing Business / Net Sales ¥1.27 billion / Segment profit ¥370 million / Timing 2029/09 |
| Non-financial targets | Indicator Number of Test Center users / Target value 1.525 million people / Timing 2029/09, Indicator Number of contracts won in the contract business / Target value 100 contracts / Timing 2029/09 |
| Plan assumptions | There are approximately 1,000 qualification examinations in Japan, of which approximately 360 have been converted to CBT, The market for major examinations is approximately ¥70 billion, the PBT market is ¥55 billion, and the market expected to convert to CBT in the short to medium term is approximately ¥31 billion, The market in which EIF can be leveraged (SAM) is at least ¥200 billion, comprising at least ¥60 billion in existing areas and at least ¥140 billion in new areas |
| Key initiatives | Capture demand from the expansion of CBT adoption, Enhance operations to improve profitability, Undertake large-scale projects (continued orders in the public sector), Develop and expand services tailored to customers (horizontal expansion leveraging EIF), Use EIF to turn common components into services, Integrate services into operators' offerings and expand into new areas |
| Results under the previous plan | 2026/09 revised forecast: revenue of ¥5.80 billion and operating profit of ¥80 million → 2026/09 actual: revenue of ¥5.80 billion and operating profit of ¥190 million(Revenue was in line with the forecast, while operating profit exceeded the full-year forecast) |
| Size of the Target Market | Market for major examinations: approximately ¥70 billion. PBT market: ¥55 billion; CBT examinations: ¥15 billion; market expected to convert to CBT in the short to medium term: ¥31 billion. Market in which EIF can be leveraged (SAM): at least ¥200 billion, comprising at least ¥60 billion in existing areas and at least ¥140 billion in new areas. Source: The company's estimates based on publicly available materials from the respective examination organizations, and prepared by the company based on the Ministry of Education, Culture, Sports, Science and Technology's School Basic Survey and Implementation Status of Entrance Examinations for National, Public and Private Universities, the Ministry of Health, Labour and Welfare's Status of Notifications of the Employment Status of Foreign Nationals, and other sources. |
| Risks identified | Relationships with specific customers, Impact of bidding results, Impact of Japan's declining birthrate, System failures and personal information protection management, Recruitment and Talent Development, Internal Controls |
| Publication date | 12 November 2026 |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The objective is to accelerate business growth by leveraging competitive advantages and EIF, starting with a recovery in performance through structural reform. In the test center business, the company will capture demand for computer-based testing (CBT), while in the contract and licensing businesses, it will use EIF to convert knowledge gained from individual projects into reusable assets and expand the businesses.